content

Polycarbonate: A Crucial Material In Healthcare Solutions

Polycarbonate plastic, which is produced through the use of the well-studied, building-block chemistry known as Bisphenol A, or BPA, plays an important role in...

Extractables & Leachables : Risks, Testing, And Innovations

Understanding the Impact of Extractables and Leachables (E&L) on Drug Safety Extractables and leachables (E&L) pose two primary risks: contamination from harmful impurities like nitrosamine...

QIAGEN’s role in advancing companion diagnostics for precision medicine

In the evolving landscape of healthcare, precision medicine has emerged as a game-changer, promising tailored treatments and improved patient outcomes. At the forefront of...

Envision Pharma Group launches EnvisionOne Insights: A unified data and analytics solution for medical affairs

Leading global technology solutions partner, Envision Pharma Group, has launched its new data and analytics management solution, EnvisionOne Insights, to harness the full power...

Tower Cold Chain Partners With Cryopdp To Expand Temperature Range

Temperature-controlled container specialists Tower Cold Chain and CRYOPDP have partnered to enhance their product offerings to the pharmaceutical supply chain. The collaboration aims to...

Seeq Appoints Vertix as First Master Regional VAR Partner for the Caribbean and Latin American Region

Seeq, a leader in industrial analytics and AI, and Vertix Technologies SAC, a solutions-driven company specializing in Industry 4.0, digital transformation and advanced analytics...

Quotient Sciences and Vasa Therapeutics Announce Dosing of First Subjects with VS-041, a Novel Heart Failure Treatment

VS-041, a novel and potentially life-saving  treatment for heart failure, developed by Vasa Therapeutics, a San Diego-based biotechnology  company, has reached a major clinical milestone with the first human subjects dosed at Quotient  Sciences’ Nottingham, UK clinic. In this...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read